Last month, Allergan announced a voluntary global recall of BIOCELL textured breast implants and tissue expanders, due to their link to an increased risk of breast implant-associated anaplastic large cell lymphoma, or BIA-ALCL.

The first injectable neurotoxin to receive approval in nearly a decade, Jeuveau joins Dysport, Xeomin, and of course, Botox, as the fourth product for treating frown lines and other expression lines such as crow’s feet and brow furrows.

Last year alone, over 43,000 American women opted to have breast reduction surgery—and this procedure is well-known for helping to improve the daily lives of women who have had it.

In 2016, the World Health Organization, and subsequently the FDA, officially linked certain breast implants to a very rare form of cancer called breast implant associated anaplastic large cell lymphoma, or BIA-ALCL.

Did you know that women make up nearly half of hair loss sufferers in the US? Despite this startling statistic, many still incorrectly believe that hair loss is something that only plagues men.

Ever wondered just how many people are having cosmetic procedures done? The American Society of Plastic Surgeons wants to know too.